Strengthening Global Commitments to UHC for Psoriatic Disease

In September 2023, a second High-Level Meeting on Universal Health Coverage (UHC) creates an opportunity for governments to renew their commitments toward UHC and the health priorities that it encompasses, including non-communicable diseases (NCDs) and psoriatic disease.

Fulfilling worldwide commitments to achieve universal health coverage would substantially improve global health and particularly the lives of people living with chronic conditions like psoriatic disease. UHC is key to reducing the burden of psoriatic disease by ensuring that populations have access to affordable basic healthcare, medicines, and treatment, and that individuals can be quickly and accurately diagnosed and receive early and appropriate treatment. As countries come closer to these global commitments, they can also strengthen their healthcare workforce to ensure that general practitioners have appropriate training for general management of skin diseases.

In this report, we explore current barriers in access to psoriatic disease care globally, such as:

• Access to primary care
• Access to medication and treatment
• Access to reimbursement

We also present a series of case studies addressing the abovementioned barriers, and how these case studies also represent best practices of UHC implementation.